Correlation Between Nanobiotix and Innate Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nanobiotix and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanobiotix and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanobiotix SA and Innate Pharma, you can compare the effects of market volatilities on Nanobiotix and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanobiotix with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanobiotix and Innate Pharma.

Diversification Opportunities for Nanobiotix and Innate Pharma

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Nanobiotix and Innate is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Nanobiotix SA and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Nanobiotix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanobiotix SA are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Nanobiotix i.e., Nanobiotix and Innate Pharma go up and down completely randomly.

Pair Corralation between Nanobiotix and Innate Pharma

Assuming the 90 days trading horizon Nanobiotix SA is expected to generate 1.63 times more return on investment than Innate Pharma. However, Nanobiotix is 1.63 times more volatile than Innate Pharma. It trades about 0.23 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.12 per unit of risk. If you would invest  307.00  in Nanobiotix SA on November 3, 2024 and sell it today you would earn a total of  43.00  from holding Nanobiotix SA or generate 14.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nanobiotix SA  vs.  Innate Pharma

 Performance 
       Timeline  
Nanobiotix SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nanobiotix SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Innate Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Innate Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Nanobiotix and Innate Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nanobiotix and Innate Pharma

The main advantage of trading using opposite Nanobiotix and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanobiotix position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.
The idea behind Nanobiotix SA and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated